BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 26313665)

  • 1. Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma.
    Oguejiofor K; Hall J; Slater C; Betts G; Hall G; Slevin N; Dovedi S; Stern PL; West CM
    Br J Cancer; 2015 Sep; 113(6):886-93. PubMed ID: 26313665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.
    van Kempen PM; Noorlag R; Swartz JE; Bovenschen N; Braunius WW; Vermeulen JF; Van Cann EM; Grolman W; Willems SM
    Cancer Immunol Immunother; 2016 May; 65(5):575-85. PubMed ID: 26993499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis.
    Jung AC; Guihard S; Krugell S; Ledrappier S; Brochot A; Dalstein V; Job S; de Reynies A; Noël G; Wasylyk B; Clavel C; Abecassis J
    Int J Cancer; 2013 Jan; 132(2):E26-36. PubMed ID: 22890882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
    Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
    J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma.
    Nordfors C; Grün N; Tertipis N; Ährlund-Richter A; Haeggblom L; Sivars L; Du J; Nyberg T; Marklund L; Munck-Wikland E; Näsman A; Ramqvist T; Dalianis T
    Eur J Cancer; 2013 Jul; 49(11):2522-30. PubMed ID: 23571147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct patterns of infiltrating CD8+ T cells in HPV+ and CD68 macrophages in HPV- oropharyngeal squamous cell carcinomas are associated with better clinical outcome but PD-L1 expression is not prognostic.
    Oguejiofor K; Galletta-Williams H; Dovedi SJ; Roberts DL; Stern PL; West CM
    Oncotarget; 2017 Feb; 8(9):14416-14427. PubMed ID: 28122336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.
    Wagner S; Wittekindt C; Reuschenbach M; Hennig B; Thevarajah M; Würdemann N; Prigge ES; von Knebel Doeberitz M; Dreyer T; Gattenlöhner S; Klussmann JP
    Int J Cancer; 2016 May; 138(9):2263-73. PubMed ID: 26662627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes.
    De Meulenaere A; Vermassen T; Aspeslagh S; Zwaenepoel K; Deron P; Duprez F; Rottey S; Ferdinande L
    Pathology; 2017 Jun; 49(4):397-404. PubMed ID: 28427753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8
    Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
    Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency.
    Punt S; Dronkers EA; Welters MJ; Goedemans R; Koljenović S; Bloemena E; Snijders PJ; Gorter A; van der Burg SH; Baatenburg de Jong RJ; Jordanova ES
    Cancer Immunol Immunother; 2016 Apr; 65(4):393-403. PubMed ID: 26899388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression.
    Xu SM; Shi CJ; Xia RH; Wang LZ; Tian Z; Ye WM; Liu L; Liu SL; Zhang CY; Hu YH; Zhou R; Han Y; Wang Y; Zhang ZY; Li J
    Front Immunol; 2021; 12():798424. PubMed ID: 35145511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune cells and prognosis in HPV-associated oropharyngeal squamous cell carcinomas: Review of the literature.
    Saber CN; Grønhøj Larsen C; Dalianis T; von Buchwald C
    Oral Oncol; 2016 Jul; 58():8-13. PubMed ID: 27311396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
    Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
    J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV Epitope Processing Differences Correlate with ERAP1 Allotype and Extent of CD8
    Reeves E; Wood O; Ottensmeier CH; King EV; Thomas GJ; Elliott T; James E
    Cancer Immunol Res; 2019 Jul; 7(7):1202-1213. PubMed ID: 31151965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LAG-3, TIM-3 and VISTA Expression on Tumor-Infiltrating Lymphocytes in Oropharyngeal Squamous Cell Carcinoma-Potential Biomarkers for Targeted Therapy Concepts.
    Wuerdemann N; Pütz K; Eckel H; Jain R; Wittekindt C; Huebbers CU; Sharma SJ; Langer C; Gattenlöhner S; Büttner R; Speel EJ; Suchan M; Wagner S; Quaas A; Klussmann JP
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ratio of CD4/CD8 T-cells in human papillomavirus-positive laryngeal squamous cell carcinoma accounts for improved outcome.
    Zhang D; Tang WJ; Tang D; Zhou J; Chou L; Tao L; Lu LM
    Acta Otolaryngol; 2016 Aug; 136(8):826-33. PubMed ID: 27080151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of tumour-infiltrating lymphocytes as a prognostic factor in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Ruangritchankul K; Sandison A; Warburton F; Guerrero-Urbano T; Reis Ferreira M; Lei M; Thavaraj S
    Histopathology; 2019 Jul; 75(1):146-150. PubMed ID: 31144335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an excellent prognosis subset of human papillomavirus-associated oropharyngeal cancer patients by quantification of intratumoral CD103+ immune cell abundance.
    Solomon B; Young RJ; Bressel M; Cernelc J; Savas P; Liu H; Urban D; Thai A; Cooper C; Fua T; Neeson P; Loi S; Porceddu SV; Rischin D
    Ann Oncol; 2019 Oct; 30(10):1638-1646. PubMed ID: 31400196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
    Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
    Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.